title: Didactic migraine education in US doctor of pharmacy programs.
abstract: OBJECTIVE
  To compare didactic migraine education in doctor of pharmacy (PharmD) programs in the United States with the Headache Consortium's evidence-based migraine treatment recommendations.
  
  
  METHODS
  A self-administered survey instrument was mailed to all 90 Accreditation Council for Pharmacy Education (ACPE) approved PharmD programs in the United States.
  
  
  RESULTS
  Seventy-seven programs responded (86%) and 69 useable survey instruments were analyzed. Fifty-five percent of programs discussed the Consortium's guidelines, 49% discussed the selection of nonprescription versus prescription agents, 45% recommended a butalbital-containing product as migraine treatment, and 20% educated students about tools for assessing migraine-related debilitation. At least 50% of programs taught information consistent with the remaining Consortium recommendations.
  
  
  CONCLUSIONS
  Approximately half of the PharmD programs teach concepts about migraine headache treatment consistent with the US Headache Consortium's recommendations.
authors.affiliation: Diamond Headache Clinic Inpatient Unit, St. Joseph Hospital, Chicago, IL 60657, USA. rich.wenzel@hotmail.com
authors.forename: Richard G
authors.initials: RG
authors.lastname: Wenzel
authors.forename: Rosalyn S
authors.initials: RS
authors.lastname: Padiyara
authors.forename: Jon C
authors.initials: JC
authors.lastname: Schommer
mesh_terms: D003430:Cross-Sectional Studies; D003479:Curriculum / Q000592:standards; D003625:Data Collection / Q000379:methods; D004514:Education, Pharmacy, Graduate / Q000379:methods* / Q000592:standards; D006801:Humans; D008881:Migraine Disorders / Q000628:therapy*; D017410:Practice Guidelines as Topic / Q000592:standards; D014481:United States